Medicare Enrolled

Dr. Alex Guevara, D.O.

Family Medicine · Fort Worth, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
1217 GRAND AVE, Fort Worth, TX 76106
8176257733
In practice since 2005 (20 years)
NPI: 1699768481 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Guevara from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Guevara? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Guevara

Dr. Alex Guevara is a family medicine in Fort Worth, TX, with 20 years in practice. Based on federal Medicare data, Dr. Guevara performed 8,428 Medicare services across 920 unique beneficiaries.

Between the years covered by Open Payments, Dr. Guevara received a total of $15,261 from 66 pharmaceutical and/or device companies across 771 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Guevara is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 2% volume in TX$ $15,261 industry payments

Medicare Practice Summary

Medicare Utilization ↗
8,428
Medicare services
Top 2% in TX for family medicine
920
Unique beneficiaries
$17
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~421 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Allergy skin test3,024$3$10
Allergy immunotherapy preparation1,960$11$21
Injection, magnesium sulfate, per 500 mg528$1$20
Office visit, established patient (30-39 min)421$87$190
Injection, potassium chloride, per 2 meq325$0$20
Office visit, established patient, complex (40-54 min)231$118$377
Blood draw (venipuncture)228$8$38
Office visit, established patient (20-29 min)183$66$115
Office visit, established patient (10-19 min)172$40$100
Unclassified drugs131$2$231
Injection of additional new drug or substance into vein120$12$40
Drug injection, under skin or into muscle112$9$72
Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or106$22$99
Urinalysis, manual87$3$50
Injection, pyridoxine hcl, 100 mg85$9$50
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less66$22$65
Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion66$15$40
Injection of drug or substance into vein66$29$65
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less65$50$145
Electrocardiogram (EKG), 12-lead55$10$100
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg51$1$40
Stool analysis for blood, by fecal hemoglobin determination by immunoassay49$14$50
Annual wellness visit, follow-up49$127$230
Infusion, normal saline solution , 1000 cc49$2$100
Steroid injection (triamcinolone)46$1$24
Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes33$25$55
Ceftriaxone antibiotic injection26$0$58
Urine microalbumin test (kidney screening)24$5$50
Chest X-ray, 2 views19$24$125
Smear for infectious agents19$5$17
Injection, lidocaine hcl for intravenous infusion, 10 mg17$0$25
Face-to-face behavioral counseling for obesity, 15 minutes15$25$55
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
3.1% high complexity
16.1% medium
80.8% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$15,261
Total received (2018-2024)
Avg $2,180/year across 7 years
Top 2% in TX for family medicine
66
Companies
771
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,974 (91.6%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,287 (8.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,423
2023
$1,579
2022
$2,494
2021
$2,615
2020
$1,731
2019
$3,009
2018
$2,409

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$2,883
Novo Nordisk Inc
$1,468
Amarin Pharma Inc.
$957
Gilead Sciences, Inc.
$898
Boehringer Ingelheim Pharmaceuticals, Inc.
$884
Lilly USA, LLC
$853
Amgen Inc.
$500
GlaxoSmithKline, LLC.
$485
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$437
Merck Sharp & Dohme Corporation
$429
SANOFI-AVENTIS U.S. LLC
$425
Janssen Pharmaceuticals, Inc
$423
Bayer HealthCare Pharmaceuticals Inc.
$386
Corcept Therapeutics
$341
Kowa Pharmaceuticals America, Inc.
$310
Abbott Laboratories
$303
RedHill Biopharma Inc.
$237
Bayer Healthcare Pharmaceuticals Inc.
$211
Esperion Therapeutics, Inc.
$159
Optinose US, Inc.
$150
PFIZER INC.
$141
AbbVie Inc.
$138
Mannkind Corporation
$118
Neos Therapeutics, LP
$115
ABBVIE INC.
$110
ARBOR PHARMACEUTICALS, INC.
$106
Merck Sharp & Dohme LLC
$98
Arbor Pharmaceuticals, Inc.
$94
Horizon Therapeutics plc
$92
Astellas Pharma US Inc
$88
Horizon Pharma plc
$88
OptiNose US, Inc.
$87
Phathom Pharmaceuticals, Inc.
$86
Althera Pharmaceuticals LLC
$79
Novartis Pharmaceuticals Corporation
$72
VIVUS, Inc.
$70
Antares Pharma, Inc.
$68
Vertical Pharmaceuticals, LLC
$61
Genentech USA, Inc.
$59
Ferring Pharmaceuticals Inc.
$56
Paratek Pharmaceuticals, Inc.
$54
Azurity Pharmaceuticals, Inc.
$53
Takeda Pharmaceuticals U.S.A., Inc.
$51
Nabriva Therapeutics, plc
$51
IDORSIA PHARMACEUTICALS US INC
$44
Allergan Inc.
$39
Xeris Pharmaceuticals, Inc.
$38
Shire North American Group Inc
$37
Exact Sciences Corporation
$36
Dexcom, Inc.
$36
Regeneron Healthcare Solutions, Inc.
$27
Boston Scientific Corporation
$23
SI-BONE, Inc.
$18
BOSTON SCIENTIFIC CORPORATION
$18
MITSUBISHI TANABE PHARMA AMERICA, INC.
$18
Noden Pharma USA Inc
$18
Eisai Inc.
$16
CeQur Corporation
$15
SI-BONE, INC.
$13
Lupin Inc.
$13
Novum Pharma, LLC
$13
Orexigen Therapeutics, Inc.
$13
Exeltis, USA Inc.
$13
Zyla Life Sciences
$13
Adhera Therapeutics, Inc.
$12
Medtronic Vascular, Inc.
$12
Top 3 companies account for 34.8% of total payments
Associated products mentioned in payments ›
AFREZZA · AIRSUPRA · Adzenys XR-ODT · Aemcolo · Aimovig · Alcortin A · BASAGLAR · BELSOMRA · BREO · BREZTRI · BYDUREON · BYSTOLIC · CHANTIX · CONTRAVE · CeQur Simplicity · Cologuard Collection Kit · DIABETES - DISEASE · DUEXIS · Dayvigo · Descovy · Dexcom G6 Transmitter · EDARBI · ELIQUIS · EMGALITY · ENTRESTO · EUCRISA · EUFLEXXA · Edarbi · Edarbyclor · FARXIGA · FREESTYLE LIBRE · FreeStyle Libre · FreeStyle Libre blood glucose Flash Monitoring System · GENERAL FEMALE SUI · GLYXAMBI · Horizant · IFUSE IMPLANT · INVOKANA · JANUVIA · JARDIANCE · Kerendia · Korlym · LINZESS · LIVALO · LOKELMA · LORZONE · LYRICA · Livalo · MOUNJARO · MYRBETRIQ · Movantik · Myrbetriq · NEXLETOL · NOCDURNA · NO_PRODUCT · NUZYRA · OFEV · OTREXUP · Otezla · Ozempic · PAXLOVID · PENNSAID · PRALUENT · PREMARIN · PRESTALIA · Proclaim IPG · Prolia · QSYMIA · QUVIVIQ · RADICAVA · RAYOS · RECORLEV · RELEXXII · Ranexa · Repatha · Roszet · Rybelsus · SEGLENTIS · SHINGRIX · SOLIQUA · SOLIQUA 100/33 · SOLOSEC · STEGLATRO · SYMBICORT · SYNJARDY · SYNTHROID · TEKTURNA · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TRULANCE · TRULICITY · TZIELD · Talicia · Trintellix · Truvada · TurboHawk · UBRELVY · VIBERZI · VIMOVO · VOQUEZNA · Vascepa · Veozah · Victoza · Vitafol Ultra · WaveWriter Alpha Prime 16 · Wegovy · XARELTO · XIFAXAN · XYOSTED · Xenleta · Xhance · Xofluza · ZORVOLEX · ZORYVE · iFuse Implant
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (92%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 2% for family medicine in TX.

Equivalent to $181 per 100 Medicare services performed
Looking for a family medicine in Fort Worth?
Compare family medicines in the Fort Worth area by procedure volume, costs, and industry payment transparency.
Browse family medicines nearby

Geographic Context

Family Medicines within 10 mi
1,013
Per 100K population
47.4
County median income
$81,905
Nearest hospital
JPS HEALTH NETWORK
6.6 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Guevara is a mixed practice specialist, with above-average Medicare volume (top 2% in TX), and high industry engagement (low-engagement, top 2%), with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Guevara experienced with allergy skin test?
Based on Medicare claims data, Dr. Guevara performed 3,024 allergy skin test services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Guevara receive payments from pharmaceutical companies?
Yes. Dr. Guevara received a total of $15,261 from 66 companies across 771 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Guevara's costs compare to other family medicines in Fort Worth?
Dr. Guevara's average Medicare payment per service is $17. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Guevara) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →